ENDRA Life Sciences (NDRA) Income from Continuing Operations: 2016-2024
Historic Income from Continuing Operations for ENDRA Life Sciences (NDRA) over the last 9 years, with Dec 2024 value amounting to -$11.5 million.
- ENDRA Life Sciences' Income from Continuing Operations fell 37.94% to -$3.1 million in Q4 2021 from the same period last year, while for Dec 2021 it was -$11.2 million, marking a year-over-year increase of 4.22%. This contributed to the annual value of -$11.5 million for FY2024, which is 14.39% down from last year.
- Latest data reveals that ENDRA Life Sciences reported Income from Continuing Operations of -$11.5 million as of FY2024, which was down 14.39% from -$10.1 million recorded in FY2023.
- In the past 5 years, ENDRA Life Sciences' Income from Continuing Operations registered a high of -$10.1 million during FY2023, and its lowest value of -$13.2 million during FY2022.
- In the last 3 years, ENDRA Life Sciences' Income from Continuing Operations had a median value of -$11.5 million in 2024 and averaged -$11.6 million.
- As far as peak fluctuations go, ENDRA Life Sciences' Income from Continuing Operations declined by 17.34% in 2022, and later climbed by 23.67% in 2023.
- ENDRA Life Sciences' Income from Continuing Operations (Yearly) stood at -$11.7 million in 2020, then climbed by 4.22% to -$11.2 million in 2021, then dropped by 17.34% to -$13.2 million in 2022, then rose by 23.67% to -$10.1 million in 2023, then declined by 14.39% to -$11.5 million in 2024.